Psybio Therapeutics Corp
Change company Symbol lookup
Select an option...
PSYBF Psybio Therapeutics Corp
OLO Olo Inc
MTC MMTEC Inc
IGMS IGM Biosciences Inc
FNCB FNCB Bancorp Inc
DXCM Dexcom Inc
APLS Apellis Pharmaceuticals Inc
RA Brookfield Real Assets Income Fund Inc.
KRNLU Kernel Group Holdings Inc
XPEV Xpeng Inc
Go

Health Care : Biotechnology |
Company profile

PsyBio Therapeutics Corp. is a Canada-based biotechnology company. The Company is focused on discovering and developing psycho-focused therapeutics to improve mental and neurological health. It is focused on understanding the value of tryptamines and other related psycho-targeted molecules as therapeutic candidates to improve mental and neurological health. The Company is engaged in research and development for occurring psychoactive tryptamines, which is originally discovered in different varieties of hallucinogenic mushrooms, other tryptamines and phenethylamines and combinations. The Company utilizes a bio-medicinal chemistry approach to therapeutic development, in which psychoactive compounds can be utilized as a template upon, which to develop precursors and analogs, both naturally and non-naturally occurring.

Closing Price
$0.0439
Day's Change
0.0103 (30.70%)
Bid
--
Ask
--
B/A Size
--
Day's High
0.0463
Day's Low
0.0439
Volume
(Light)
Volume:
1,486

10-day average volume:
17,878
1,486
  • Prev Close
    0.0336
  • Today's Open
    0.0463
  • Day's Range
    0.0439-0.0463
  • Avg Vol (10-day)
    17.9K
  • Last (time)
    10:16a ET 11/25/22
  • Last (size)
    500
  • 52-Wk Range
    0.029 - 0.2925
    LowHigh
  • (11/29/21 - 11/21/22)
    51.21%
  • 183.3%
  • Market Cap
    4.9M
  • Shares Outstanding
    111.3M
  • -0.09
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • --
  • 16.69
  • --

Latest News

No articles or videos found.

Events

There are no calendar events for PSYBF.

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.